Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[CA 125 kinetic pattern during chemotherapy].

G Carcenac1, A Georges, L Bordenave

  • 1Service de médecine nucléaire, Hôpital du Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33600 Pessac. gcarcenac@yahoo.fr

Annales De Biologie Clinique
|March 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nature of Metallic and Insulating Domains in the Charge-Density-Wave System 1T-TaSe_{2}.

Physical review letters·2025
Same author

Fate of Quasiparticles at High Temperature in the Correlated Metal Sr_{2}RuO_{4}.

Physical review letters·2023
Same author

Mott insulators with boundary zeros.

Nature communications·2023
Same author

Distinct spin and orbital dynamics in Sr<sub>2</sub>RuO<sub>4</sub>.

Nature communications·2023
Same author

[Long-duration home hospitalization: the impacts of socio-demographic and clinical factors and care pathways].

Revue d'epidemiologie et de sante publique·2022
Same author

Comparison of perfused volume segmentation between cone-beam CT and <sup>99m</sup>Tc-MAA SPECT/CT for treatment dosimetry before selective internal radiation therapy using <sup>90</sup>Y-glass microspheres.

Diagnostic and interventional imaging·2020
Same journal

[The role of the heart-on-a-chip to drug evaluation].

Annales de biologie clinique·2026
Same journal

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Annales de biologie clinique·2026
Same journal

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

Annales de biologie clinique·2026
Same journal

Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

Annales de biologie clinique·2026
Same journal

[Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

Annales de biologie clinique·2026
Same journal

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026
See all related articles

CA 125 monitoring during chemotherapy can predict treatment success in ovarian cancer. Specific CA 125 levels reliably indicate whether residual tumors persist after treatment, aiding patient management.

Area of Science:

  • Oncology
  • Biochemistry

Context:

  • CA 125 is a tumor marker for epithelial ovarian tumors, not ideal for diagnosis.
  • Serum CA 125 levels can monitor chemotherapy effectiveness.

Purpose:

  • To evaluate CA 125 serum variations for monitoring chemotherapy efficiency in ovarian cancer patients.
  • To correlate CA 125 kinetics with tumor residue persistence post-treatment.

Summary:

  • This study analyzed CA 125 serum variations in 75 patients undergoing surgery and chemotherapy.
  • Mono-exponential regression slopes and half-lives of CA 125 were calculated.
  • Specific slope and half-life values accurately predicted the presence or absence of detectable residual tumors.

Impact:

  • A slope > -0.0156 (half-life > 44.43 days) predicted persistent tumors.

Related Experiment Videos

  • A slope < -0.0340 (half-life < 20.39 days) reliably predicted no detectable tumors.
  • Personalized CA 125 graphic representation can improve patient monitoring when combined with prognostic factors.